Skip to main content

Advertisement

Log in

Procalcitonin: diagnostic value in systemic infections in chronic kidney disease or renal transplant patients

  • Nephrology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Purpose

Although procalcitonin (PCT) has been described as a marker of infection and inflammation, it has not been extensively studied in patients with chronic kidney disease (CKD), end stage renal disease, or renal transplant.

Methods

PCT was routinely tested in 82 (56 dialyzed patients and 28 renal transplant recipients) consecutive cases with a strong clinical suspicion of infection, during a 6-month period, in a single referral unit.

Results

During the study period, 58/82 cases had confirmed infections as per definition. Patients with confirmed infections had higher values for PCT [median = 2.5 ng/mL, interquartile range (IR) = 0.9–5 ng/mL] than those without (median = 0.3 ng/mL, IR = 0.1–0.5 ng/mL), p < 0.001. Overall, for a cutoff value of 0.5 ng/mL, the sensitivity of the test was 93.1 % and the specificity 78.6.

Conclusion

Our data indicate that significantly elevated PCT concentrations offer good sensitivity and specificity for the early diagnosis of systemic bacterial infection in patients with CKD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Carrigan SD, Scott G, Tabrizian M (2004) Toward resolving the challenges of sepsis diagnosis. Clin Chem 50:1301–1314

    Article  CAS  PubMed  Google Scholar 

  2. Jaimes F, Arango C, Ruiz G et al (2004) Predicting bacteremia at the bedside. Clin Infect Dis 38:357–362

    Article  PubMed  Google Scholar 

  3. Bone RC, Balk RA, Cerra FB et al (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644–1655

    Article  CAS  PubMed  Google Scholar 

  4. Reynvoet E, Vandijck DM, Blot SI et al (2009) Epidemiology of infection in critically ill patients with acute renal failure. Crit Care Med 37:2203–2209

    Article  PubMed  Google Scholar 

  5. Davenport A (2009) Peritonitis remains the major clinical complication of peritoneal dialysis. The London, UK, peritonitis audit 2002–2003. Perit Dial Int 29:297–302

    PubMed  Google Scholar 

  6. Hildebrand A, Komenda P, Miller L et al (2010) Peritonitis and exit site infections in first nations patients on peritoneal dialysis. Clin J Am Soc Nephrol 5:1988–1995

    Article  PubMed  Google Scholar 

  7. James MT, Laupland KB, Tonelli M et al (2008) Risk of blood stream infectionin patients with chronic kidney disease not treated with dialysis. Arch Intern Med 168:2333–2339

    Article  PubMed  Google Scholar 

  8. James MT, Quan H, Tonelli M et al (2009) CKD and risk of hospitalization and death with pneumonia. Am J Kidney Dis 54:24–32

    Article  PubMed  Google Scholar 

  9. Lever A, Mackenzie I (2007) Sepsis: definition, epidemiology, and diagnosis. BMJ 335:879–883

    Article  CAS  PubMed  Google Scholar 

  10. Bossink A, Groeneveld J, Lambertus G (1999) Prediction of microbial infection and mortality in medical patients with fever: plasma procalcitonin, neutrophilic elastase-alpha-antitrypsin and lactoferrin compared with clinical variables. Clin Infect Dis 29:398–407

    Article  CAS  PubMed  Google Scholar 

  11. Lu X-L, Xiao Z-H, Yang M-Y et al (2012) Diagnostic value of serum procalcitonin in patients with chronic renal insufficiency: a systematic review and meta-analysis. Nephrol Dial Transplant 28:122–129

    Article  PubMed  Google Scholar 

  12. Tang H, Huang T, Jing J et al (2009) Effect of procalcitonin-guided treatment in patients with infections: a systematic review and meta-analysis. Infection 37:497–507

    Article  CAS  PubMed  Google Scholar 

  13. Jones AE, Fiechtl JF, Brown MD et al (2007) Procalcitonin test in the diagnosis of bacteremia: a meta-analysis. Ann Emerg Med 50:34–41

    Article  PubMed  Google Scholar 

  14. Guz G, Colak B, Hizel K et al (2006) Procalcitonin and conventional markers of inflammation in peritoneal dialysis patients and peritonitis. Perit Dial Int 26:240–248

    CAS  PubMed  Google Scholar 

  15. Simon L, Gauvin F, Amre DK et al (2004) Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 39:206–217

    Article  CAS  PubMed  Google Scholar 

  16. Lam MF, Leung JC, Lam CW et al (2008) Procalcitonin fails to differentiate inflammatory status or predict long-term outcomes in peritoneal dialysis-associated peritonitis. Perit Dial Int 28:377–384

    PubMed  Google Scholar 

  17. Öztürk R, Yilmaz GR, Bulut C et al (2010) Assessment of procalcitonin and other inflammatory markers in peritoneal dialysis-related peritonitis. Turk J Med Sci 40:199–206

    Google Scholar 

  18. Yilmaz FM, Yilmaz G, Akay H et al (2007) Evaluation of a card test for procalcitonin in continuous ambulatory peritoneal dialysis peritonitis. Ann Clin Biochem 44:482–484

    Article  CAS  PubMed  Google Scholar 

  19. Steinbach G, Bolke E, Grunert A et al (2004) Procalcitonin in patients with acute and chronic renal insufficiency. Wien Klin Wochenschr 116:849–853

    Article  CAS  PubMed  Google Scholar 

  20. Amour J, Birenbaum A, Langeron O et al (2008) Influence of renal dysfunction on the accuracy of procalcitonin for the diagnosis of postoperative infection after vascular surgery. Crit Care Med 36:1147–1154

    Article  CAS  PubMed  Google Scholar 

  21. Levy MM, Fink MP, Marshall JC et al (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Intensive Care Med 29(4):530–538

    Article  PubMed  Google Scholar 

  22. Woodhead M, Blasi F, Ewig S et al (2011) Guidelines for the management of adult lower respiratory tract infections. Clin Microbiol Infect 17(Suppl 6):E1–E59

    Article  PubMed  Google Scholar 

  23. Gupta K, Hooton TM, Naber KG et al (2011) International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 52(5):e103–e120

    Article  PubMed  Google Scholar 

  24. Farthing M, Salam M, Lindberg G et al (2012) World Gastroenterology Organisation global guidelines: Acute diarrhea in adults and children: a global perspective. Feb 2012. http://www.worldgastroenterology.org/assets/export/userfiles/Acute%20Diarrhea_long_FINAL_120604.pdf

  25. ISPD Guidelines/Recommendations (2010) Peritoneal dialysis related infections recommendations: 2010 update. Perit Dial Int 30:393

    Article  Google Scholar 

  26. Hanley JA, McNeil BJ (1983) A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148(3):839–843

    CAS  PubMed  Google Scholar 

  27. Meisner M, Huttemann E, Lohs T et al (2000) Elimination of procalcitonin and plasma concentrations during continuous veno-venous haemodiafiltration in septic patients. Eur J Anaesthesiol 17:665–671

    Article  CAS  PubMed  Google Scholar 

  28. Meisner M, Hüttemann E, Lohs T et al (2001) Plasma concentrations and clearance of procalcitonin during continuous veno-venous hemofiltration in septic patients. Shock 15(3):171–175

    Article  CAS  PubMed  Google Scholar 

  29. Meisner M, Lohs T, Huettemann E et al (2001) The plasma elimination rate and urinary secretion of procalcitonin in patients with normal and impaired renal function. Eur J Anaesthesiol 18:79–87

    Article  CAS  PubMed  Google Scholar 

  30. Eberhard OK, Langefeld I (1998) Procalcitonin in the early phase after renal transplantation—will it add to diagnostic accuracy? Clin Transpl 12(3):206–211

    CAS  Google Scholar 

  31. Hammer S, Meisner F, Dirschedl P et al (2000) Procalcitonin for differential diagnosis of graft rejection and infection in patients with heart and/or lung grafts. Intensive Care Med 26(2):S182–S186

    Article  PubMed  Google Scholar 

  32. Sabat R, Höflich C, Döcke WD et al (2001) Massive elevation of procalcitonin plasma levels in the absence of infection in kidney transplant patients treated with pan-T-cell antibodies. Intensive Care Med 27(6):987–991

    Article  CAS  PubMed  Google Scholar 

  33. Cooper D, Sharples L, Cornelissen J et al (2001) Comparison between procalcitonin, serum amyloid A, and C-reactive protein as markers of serious bacterial and fungal infections after solid organ transplantation. Transpl Proc 33(1–2):1808–1810

    Article  CAS  Google Scholar 

  34. Hedt BL, Pagano M (2011) Health indicators: eliminating bias from convenience sampling estimators. Stat Med 30(5):560–568

    PubMed  Google Scholar 

  35. van den Broek MA, Olde Damink SW, Winkens B et al (2010) Procalcitonin as a prognostic marker for infectious complications in liver transplant recipients in an intensive care unit. Liver Transpl 16(3):402–410

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was funded by the University of Medicine and Pharmacy, Iasi (grants numbers 1640/01.02.2013, 1641/01.02.2013 and IDEI—PCE 2011).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dimitrie Siriopol.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dumea, R., Siriopol, D., Hogas, S. et al. Procalcitonin: diagnostic value in systemic infections in chronic kidney disease or renal transplant patients. Int Urol Nephrol 46, 461–468 (2014). https://doi.org/10.1007/s11255-013-0542-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-013-0542-8

Keywords

Navigation